Nothing Special   »   [go: up one dir, main page]

AR049033A1 - Factor de permisividad celular para virus y usos del mismo - Google Patents

Factor de permisividad celular para virus y usos del mismo

Info

Publication number
AR049033A1
AR049033A1 ARP050101615A AR049033A1 AR 049033 A1 AR049033 A1 AR 049033A1 AR P050101615 A ARP050101615 A AR P050101615A AR 049033 A1 AR049033 A1 AR 049033A1
Authority
AR
Argentina
Prior art keywords
viruses
same
cell
factor
permissivity factor
Prior art date
Application number
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of AR049033A1 publication Critical patent/AR049033A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Métodos y composiciones relacionados con la generacion de células huésped permisivas para el crecimiento viral, en particular del virus del síndrome reproductor y respiratorio del cerdo (PRRS). Reivindicacion 1: Un método para facilitar la infeccion de una célula de un vertebrado con el PRRSV, caracterizado porque comprende el paso de (a) dirigir una mayor expresion de un polipéptido CD163 en dicha célula de vertebrado.
ARP050101615 2004-04-23 2005-04-22 Factor de permisividad celular para virus y usos del mismo AR049033A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56521404P 2004-04-23 2004-04-23
US63473604P 2004-12-09 2004-12-09

Publications (1)

Publication Number Publication Date
AR049033A1 true AR049033A1 (es) 2006-06-21

Family

ID=35320736

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP050101615 AR049033A1 (es) 2004-04-23 2005-04-22 Factor de permisividad celular para virus y usos del mismo
ARP110104870 AR084529A2 (es) 2004-04-23 2011-12-21 Un metodo para la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados
ARP110104871 AR084530A2 (es) 2004-04-23 2011-12-21 Un metodo para facilitar la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP110104870 AR084529A2 (es) 2004-04-23 2011-12-21 Un metodo para la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados
ARP110104871 AR084530A2 (es) 2004-04-23 2011-12-21 Un metodo para facilitar la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados

Country Status (22)

Country Link
US (4) US7754464B2 (es)
EP (2) EP1742658B1 (es)
JP (2) JP5273642B2 (es)
CN (1) CN102220289B (es)
AR (3) AR049033A1 (es)
AU (2) AU2005240002B2 (es)
BR (1) BRPI0508928B1 (es)
CA (1) CA2564769C (es)
CL (1) CL2008002323A1 (es)
DK (1) DK1742658T3 (es)
EA (1) EA013071B1 (es)
ES (2) ES2530694T3 (es)
HK (1) HK1109065A1 (es)
IL (1) IL178160A0 (es)
MA (1) MA28544B1 (es)
MX (1) MXPA06012216A (es)
NO (1) NO341211B1 (es)
NZ (1) NZ550145A (es)
PL (1) PL1742658T3 (es)
TW (2) TWI354025B (es)
UY (1) UY28867A1 (es)
WO (1) WO2005107796A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005240002B2 (en) * 2004-04-23 2009-06-18 Zoetis Services Llc Cellular permissivity factor for viruses, and uses thereof
CA2675139C (en) 2007-01-12 2019-02-19 The Board Of Trustees Of The University Of Illinois Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus
EP2191271B1 (en) * 2007-07-27 2016-01-13 Universiteit Gent Permissive cells and uses thereof
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
MX2014013964A (es) * 2012-05-17 2015-03-04 Zoetis Llc Vacunacion eficaz contral el virus del sindrome reproductivo y respiratorio porcino (prrs) antes del destete.
CN103525766B (zh) * 2013-03-24 2015-06-17 西北农林科技大学 一种猪肾细胞系及其应用
GB201313235D0 (en) 2013-07-24 2013-09-04 Univ Edinburgh Antiviral Compositions Methods and Animals
CN104459160A (zh) * 2014-12-30 2015-03-25 洛阳普莱柯万泰生物技术有限公司 试剂盒及其制备方法和使用方法
GB201617559D0 (en) 2016-10-17 2016-11-30 University Court Of The University Of Edinburgh The Swine comprising modified cd163 and associated methods
MX2019006992A (es) 2016-12-14 2019-08-29 Zoetis Services Llc Vacunacion eficaz contra cepas europeas del virus del sindrome reproductivo y respiratorio porcino (prrs) previo al destete.
CN108103099B (zh) * 2017-12-18 2022-03-04 中山大学 一种抗蓝耳病Marc-145细胞系及其制备方法和应用
CN108893450B (zh) * 2018-08-13 2022-04-19 江苏省农业科学院 先天性免疫系统重构的bhk21细胞群及其细胞克隆增毒应用
CN111996213A (zh) * 2020-02-06 2020-11-27 广西大学 猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
KR102254246B1 (ko) * 2020-03-23 2021-05-20 큐벳 주식회사 항-cd163 항체 또는 이의 항원 결합 단편을 인코딩하는 핵산 분자 및 이를 포함하는 아데노바이러스 벡터, 및 이의 아프리카 돼지열병의 예방 또는 치료용도
US11796548B2 (en) * 2020-04-22 2023-10-24 The United States Of America, As Represented By The Secretary Of Agriculture Continuous stable cell line for identification of infectious African swine fever virus in clinical samples
WO2024123640A1 (en) 2022-12-06 2024-06-13 Zoetis Services Llc Methods and compositions for vaccinating piglets against prrs-1 virus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US5118937A (en) 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
AU645294B2 (en) 1989-12-22 1994-01-13 Merck Serono Sa Endogenous gene expression modification with regulatory element
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
CA2092695A1 (en) 1991-05-15 1992-11-16 Oliver Smithies Genomic modifications with homologous dna targeting
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5514545A (en) 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
ATE242485T1 (de) 1993-05-28 2003-06-15 Baylor College Medicine Verfahren und massenspektrometer zur desorption und ionisierung von analyten
ATE206455T1 (de) * 1994-04-11 2001-10-15 Akzo Nobel Nv Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des schweins
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1998035023A1 (en) * 1997-02-07 1998-08-13 Origen, Inc. Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays
US6740490B2 (en) * 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
US7563881B2 (en) 2001-07-24 2009-07-21 Intervet International B.V. Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus
WO2003100419A1 (en) * 2002-05-27 2003-12-04 Bioceros B.V. Methods for using the cd163 pathway for modulating an immune response
AU2005240002B2 (en) * 2004-04-23 2009-06-18 Zoetis Services Llc Cellular permissivity factor for viruses, and uses thereof

Also Published As

Publication number Publication date
NZ550145A (en) 2009-07-31
EP1742658B1 (en) 2014-12-24
TWI354025B (en) 2011-12-11
MA28544B1 (fr) 2007-04-03
AU2005240002B2 (en) 2009-06-18
JP5273642B2 (ja) 2013-08-28
BRPI0508928B1 (pt) 2015-10-06
US20100273238A1 (en) 2010-10-28
IL178160A0 (en) 2006-12-31
TW200604343A (en) 2006-02-01
AU2005240002A1 (en) 2005-11-17
WO2005107796A3 (en) 2007-04-12
TW201134944A (en) 2011-10-16
UY28867A1 (es) 2005-11-30
NO20065115L (no) 2006-11-06
MXPA06012216A (es) 2007-01-17
HK1109065A1 (en) 2008-05-30
CN102220289B (zh) 2014-05-21
CL2008002323A1 (es) 2008-12-19
AR084529A2 (es) 2013-05-22
AU2009202410A1 (en) 2009-07-09
US20140141492A1 (en) 2014-05-22
US7754464B2 (en) 2010-07-13
CN102220289A (zh) 2011-10-19
TWI438278B (zh) 2014-05-21
EP2520310B1 (en) 2016-03-30
EA013071B1 (ru) 2010-02-26
EP2520310A1 (en) 2012-11-07
US20050271685A1 (en) 2005-12-08
AR084530A2 (es) 2013-05-22
JP2013078324A (ja) 2013-05-02
NO341211B1 (no) 2017-09-11
US8058050B2 (en) 2011-11-15
EA200601677A1 (ru) 2007-10-26
CA2564769A1 (en) 2005-11-17
US8486685B2 (en) 2013-07-16
WO2005107796A2 (en) 2005-11-17
JP5600340B2 (ja) 2014-10-01
ES2570665T3 (es) 2016-05-19
EP1742658A4 (en) 2007-11-28
PL1742658T3 (pl) 2015-05-29
CA2564769C (en) 2013-12-17
DK1742658T3 (en) 2015-01-19
US9102912B2 (en) 2015-08-11
US20120015425A1 (en) 2012-01-19
BRPI0508928A (pt) 2007-08-14
EP1742658A2 (en) 2007-01-17
JP2007533321A (ja) 2007-11-22
ES2530694T3 (es) 2015-03-04

Similar Documents

Publication Publication Date Title
AR049033A1 (es) Factor de permisividad celular para virus y usos del mismo
AR064888A1 (es) Celulas no simias para el crecimiento del virus del sindrome reproductor y respiratorio porcino (prrs)
PH12015500773B1 (en) Methods and compositions for live attenuated viruses
WO2009024239A3 (en) Permissive cells and uses thereof
CL2008003794A1 (es) Virus de la estomatitis vesicular geneticamente modificado (vsv) que comprende por lo menos una mutacion de aminoacido en una region de alguna de las proteinas m, g y l del virus; metodo para producirlo; composicion inmunogenica que lo comprende; metodo para adaptar un virus en un cultivo celular.
AR029759A1 (es) Variante de glucoamilasa original, una construccion de adn, un vector de expresion recombinante, una celula, un proceso para convertir almidon, uso de una variante de glucoamilasa para un proceso de fermentacion y metodo para mejorar la estabilidad termica.
AR057213A1 (es) Acidos nucleicos que codifican secuencias tgev y prrsv para la expresion mejorada de secuencias prrsv
CA2409209A1 (en) Chimeric arterivirus-like particles
CA2366072A1 (en) Prrsv vaccines
ES2157522T3 (es) Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv).
WO2003062407A8 (en) INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
AR006023A1 (es) Vacuna contra el sindrome reproductivo y respiratorio porcino
BRPI0411099A (pt) composições imunogênicas que compreendem os vetores de replicon do vìrus da encefalite eqüina venezuelana e antìgenos de proteìnas de paramixovìrus
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
CL2008003821A1 (es) Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado
DE602005023342D1 (en) S (porcine reproductive und respiratory syndrome) von schweinen
AR085179A1 (es) Vacunas para el prrsv basadas en el adenovirus porcino 3
AR051853A1 (es) Vacuna para aumentar el crecimiento basada en epitopes neutralizantes
Iwakiri et al. Plywood manufacture from five species of tropical pine
MX2023002753A (es) Anticuerpos vectorizados y usos de estos.
DE602005026005D1 (de) Gefriergetrocknete zusammensetzung aus einer inaktivierten virushülle mit membranfusionsaktivität
UA89347C2 (ru) Клетки легких хлопковой крысы sigmodon hispidus для культивирования вирусов
DE60302778D1 (de) Vorrichtung für telekommunikationsdienste
JPWO2022146484A5 (es)

Legal Events

Date Code Title Description
FG Grant, registration